Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,130,300 | 529,500 | 2,390,500 | 1,962,000 | 1,461,400 |
| Depreciation Amortization | 726,000 | 357,500 | 1,379,000 | 1,039,600 | 697,200 |
| Income taxes - deferred | -666,500 | -107,100 | 36,800 | 151,900 | 121,200 |
| Accounts receivable | N/A | N/A | 117,400 | N/A | N/A |
| Accounts payable and accrued liabilities | -887,800 | N/A | -809,000 | N/A | N/A |
| Other Working Capital | -580,600 | -913,700 | -325,500 | -548,300 | -1,021,300 |
| Other Operating Activity | 1,142,400 | 49,000 | 1,669,200 | 412,300 | 67,700 |
| Operating Cash Flow | $863,800 | $-84,800 | $4,458,400 | $3,017,500 | $1,326,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 696,800 | 341,400 | 2,416,300 | 1,259,800 | 1,085,200 |
| PPE Investments | -412,500 | -188,600 | -1,147,300 | -753,800 | -456,900 |
| Net Acquisitions | -5,276,700 | -5,276,700 | -551,400 | N/A | -551,400 |
| Purchase Of Investment | -1,832,800 | -924,400 | -9,802,700 | -8,636,700 | -5,594,700 |
| Sale Of Investment | 1,750,500 | 596,200 | 11,009,400 | 7,355,500 | 5,540,100 |
| Purchase Sale Intangibles | 410,000 | 410,000 | -308,300 | N/A | N/A |
| Other Investing Activity | 5,417,900 | 5,612,900 | -5,833,400 | -955,000 | -102,800 |
| Investing Cash Flow | $343,200 | $160,800 | $-3,909,100 | $-1,730,200 | $-80,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,679,300 | -2,088,600 | 2,680,600 | 304,900 | 2,300 |
| Debt Issued | 2,505,400 | 2,182,000 | 992,900 | -41,400 | -40,900 |
| Debt Repayment | N/A | N/A | -1,034,800 | N/A | N/A |
| Common Stock Repurchased | -435,500 | -310,600 | -800,000 | -500,000 | -200,000 |
| Dividend Paid | -1,067,700 | -527,900 | -2,101,200 | -1,576,000 | -1,051,000 |
| Other Financing Activity | 32,700 | 43,900 | 96,100 | 109,000 | -8,000 |
| Financing Cash Flow | $-1,644,400 | $-701,200 | $-166,400 | $-1,703,500 | $-1,297,600 |
| Exchange Rate Effect | -118,700 | -181,600 | -341,500 | -248,200 | -12,600 |
| Beginning Cash Position | 3,871,600 | 3,871,600 | 3,830,200 | 3,830,200 | 3,830,200 |
| End Cash Position | 3,315,500 | 3,064,800 | 3,871,600 | 3,165,800 | 3,765,700 |
| Net Cash Flow | $-556,100 | $-806,800 | $41,400 | $-664,400 | $-64,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 863,800 | -84,800 | 4,458,400 | 3,017,500 | 1,326,200 |
| Capital Expenditure | -412,500 | -188,600 | -1,162,600 | -753,800 | -456,900 |
| Free Cash Flow | 451,300 | -273,400 | 3,295,800 | 2,263,700 | 869,300 |